These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8898005)

  • 1. Renin-angiotensin system modulates renal bradykinin production.
    Siragy HM; Jaffa AA; Margolius HS; Carey RM
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1090-5. PubMed ID: 8898005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1996 Apr; 97(8):1978-82. PubMed ID: 8621783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subtype 2 angiotensin receptor regulates renal prostaglandin F2 alpha formation in conscious rats.
    Siragy HM; Carey RM
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R1103-7. PubMed ID: 9321892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenal renin inhibition increases renal function by an angiotensin II-dependent mechanism.
    Siragy HM; Lamb NE; Rose CE; Peach MJ; Carey RM
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F749-54. PubMed ID: 3052111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model.
    Siragy HM; Carey RM
    Hypertension; 1999 May; 33(5):1237-42. PubMed ID: 10334818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II does not increase renal prostaglandin E2 in response to pressure reduction.
    Imanishi M; Akabane S; Kawamura M; Matsushima Y; Kuramochi M; Omae T
    Kidney Int; 1992 Aug; 42(2):417-23. PubMed ID: 1405324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake.
    Siragy HM; Ibrahim MM; Jaffa AA; Mayfield R; Margolius HS
    Hypertension; 1994 Jun; 23(6 Pt 2):1068-70. PubMed ID: 8206596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that intrarenal bradykinin plays a role in regulation of renal function.
    Siragy HM
    Am J Physiol; 1993 Oct; 265(4 Pt 1):E648-54. PubMed ID: 8238340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intrarenal ANG II in reflex neural stimulation of plasma renin activity and renal sodium reabsorption.
    Nelson LD; Osborn JL
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R392-8. PubMed ID: 8368393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F522-9. PubMed ID: 2180318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined intrarenal renin-angiotensin blockade alters renal function and this is reversed by angiotensin II.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    J Hypertens Suppl; 1989 Dec; 7(6):S174-5. PubMed ID: 2698923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
    Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
    Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
    Munger KA; Jackson EK
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F783-90. PubMed ID: 7977781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of losartan on the cardiovascular system, renal haemodynamics and function and lung liquid flow in fetal sheep.
    Stevenson KM; Gibson KJ; Lumbers ER
    Clin Exp Pharmacol Physiol; 1996 Feb; 23(2):125-33. PubMed ID: 8819640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
    Siragy HM; Jaffa AA; Margolius HS
    Hypertension; 1997 Mar; 29(3):757-62. PubMed ID: 9052892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
    Campbell DJ; Kladis A; Valentijn AJ
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.